325 East Warm Springs Road
Suite 102
Las Vegas, NV 89119
United States
702 997 5968
https://www.janone.com
Sector(es): Industrials
Industria: Waste Management
Empleados a tiempo completo: 5
Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
---|---|---|---|---|
Mr. Tony Isaac | President, CEO, Corporate Secretary, Treasurer & Director | 617.71k | N/D | 1954 |
Mr. Virland A. Johnson CPA | Chief Financial Officer | 224.35k | N/D | 1963 |
Dr. Tony Giordano Ph.D. | Chief Scientific Officer | N/D | N/D | N/D |
Dr. Douglas Flanagan | Chief Formulation Advisor | N/D | N/D | N/D |
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. Its lead product candidate is JAN101, a patented oral and sustained release pharmaceutical composition of sodium nitrite that targets poor blood flow to the extremities in patients with diabetes or peripheral artery disease to treat pain. The company was formerly known as Appliance Recycling Centers of America, Inc. and changed its name to JanOne Inc. in September 2019. JanOne Inc. was founded in 1976 and is headquartered in Las Vegas, Nevada.
La calificación ISS Governance QuickScore de JanOne Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.